challenges and status in development of gene therapies in low- and middle-income countries (lmics)
Published 1 year ago • 667 plays • Length 1:52:54Download video MP4
Download video MP3
Similar videos
-
17:14
real-world challenge: establishing the value of gene therapy for patients
-
4:05
gene therapy basics (2022 update)
-
23:15
the challenge to develop and commercialize gene-based therapies for rare diseases
-
35:01
key considerations of gene therapy development: a caregiver's story
-
3:34
gene therapy for mps
-
4:50:23
clinical gene therapy: asgct indo-uk symposium
-
4:20
gene therapy approaches (2022 update)
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
3:32
asgct: the home of cell and gene therapy
-
3:35
how safe are gene therapies? | tomorrow today - interview
-
3:23:20
advancing gene and cell therapies in south africa
-
5:04
the bridge to accelerating gene therapies: the bespoke gene therapy consortium
-
3:58:26
what to expect as a participant in a gene therapy clinical trial
-
8:29
bioanalytics in the development of cell and gene therapies
-
9:56
what does the future look like with cell and gene therapies?
-
3:04
challenges in developing gene-based therapies for neurodegenerative & neuromuscular diseases
-
3:38
gene therapy and the immunity challenges in gene therapy, explained by duchenne uk
-
47:03
current challenges, opportunities and trends in gene editing and gene therapy workshop
-
31:31
gene and cell therapies: a paradigm shift and its implications for medcomms